Skip to main content

News


Certain Cigarette Flavoring a No-No 
The FDA reminds the tobacco industry that cigarettes can no longer contain certain characterizing flavors.

by RSS Feed
Subscribe to the RSS feed.
by Email
Subscribe to the NACS Daily e-newsletter.
Share:                          
Posted: Sep 16, 2009     Email    Print    Print ALL    Comment   

WASHINGTON – On Monday, U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products sent an open letter to the tobacco industry reminding them that cigarettes “containing certain characterizing flavors are considered adulterated under the Federal Food, Drug, and Cosmetic Act (FFDCA or the Act), as amended by the Family Smoking Prevention and Tobacco Control Act (FSPTCA).”

An excerpt of the letter follows. Download a PDF for the entire text.

“Congress has stated that flavors make cigarettes more appealing to youth and often result in exposure to additional carcinogens and other toxic constituents. The removal from the market of cigarettes that contain certain characterizing flavors is an important step in FDA’s efforts to reduce the burden of illness and death caused by tobacco products.

“The FSPTCA…establishes a tobacco product standard special rule for cigarettes that states in part…a cigarette or any of its component parts (including the tobacco, filter, or paper) shall not contain, as a constituent (including a smoke constituent) or additive, an artificial or natural flavor (other than tobacco or menthol) or an herb or spice, including strawberry, grape, orange, clove, cinnamon, pineapple, vanilla, coconut, licorice, cocoa, chocolate, cherry, or coffee, that is a characterizing flavor of the tobacco product or tobacco smoke.

“As of the September 22, 2009, effective date, cigarettes and their component parts that fail to comply with the special rule established under section 907 are deemed adulterated under section 902 of the Act. Under the Act, adulterated products sold or held for sale in the United States may be subject to seizure under section 304 of the Act. In addition, manufacturers, distributors, and retailers may be subject to injunction actions, civil money penalties, and/or criminal prosecution for violating the requirements of the Act (FFDCA, sections 301, 302, 303). FDA intends to use the full range of enforcement tools within the Agency’s authority to ensure compliance with the new requirement.”